Zhao Renbin
Director/Board Member at INNOCARE PHARMA LIMITED
Net worth: 65 M $ as of 30/05/2024
Zhao Renbin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INNOCARE PHARMA LIMITED | Director/Board Member | - | - |
| General Counsel | - | - | |
| Corporate Officer/Principal | 26/09/2019 | - |
Career history of Zhao Renbin
Former positions of Zhao Renbin
| Companies | Position | Start | End |
|---|---|---|---|
BioDuro (Beijing) Co., Ltd.
 BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 28/02/2013 | 31/07/2015 |
| Shenzhou Tianchen Technology, Inc. | Director/Board Member | 28/02/2010 | 28/02/2013 |
Training of Zhao Renbin
| The Johns Hopkins University School of Medicine | Doctorate Degree |
| Tsinghua University | Undergraduate Degree |
Statistics
International
| China | 5 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| General Counsel | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| INNOCARE PHARMA LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
| Shenzhou Tianchen Technology, Inc. | |
BioDuro (Beijing) Co., Ltd.
BioDuro (Beijing) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services BioDuro (Beijing) Co., Ltd. operates as a integrated drug discovery outsourcing company that provides integrated research and development services to biopharmaceutical clients. Its services range from medicinal chemistry to discovery biology, pharmacology, drug metabolism and pharmacokinetics (DMPK) and drug safety evaluation. The company was founded in 2006 and is headquartered in Beijing, China. | Commercial Services |
- Stock Market
- Insiders
- Zhao Renbin
- Experience
